Dailypharm Live Search Close

API competition¡è with entry of Chinese and Indian pharmas

By Son, Hyung-Min | translator Kang, Shin-Kook

24.08.30 05:30:15

°¡³ª´Ù¶ó 0
CPHI Korea was held from 26th-28th in Samseong-dong, Seoul¡¦340 companies participated in the event

More than half of the participants were Chinese and Indian companies... Puts price competitiveness at the forefront

Domestic companies such as Innist ST Samoh Pharm, Suheung, Novarex, etc. also participated in the event

Chinese and Indian companies developing active pharmaceutical ingredients (APIs) are accelerating their entry into Korea. Numerous Chinese and Indian companies as well as domestic companies participated in 'CPHI Korea 2024,' an exhibition for the global pharmaceutical, bio, and health functional food industry that was held at COEX in Samseong-dong, Seoul for 3 days from the 27th, to promote their API development capabilities.

Domestic companies also participated in the event to showcase their technology. Domestic API companies highlighted the quality of their products as a strategy to differentiate themselves from overseas companies.

A large number of Chinese and Indian API companies par

Son, Hyung-Min(shm@dailypharm.com)
If you want to see the full article, please JOIN US (click)